Tong Lee: Clinical Trials

1 trial sponsored by Tong Lee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Tong Lee: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (RitalinĀ®)(OND003IND)
OND-PR002 and MPh-IR, Placebo: Two dextrose capsules for Ond-PR002 and MPh-IR - Methamphetamine Dependence, Cocaine Dependence
Phase 2CompletedTong Lee302011-08-012014-10-07

Conditions studied

Cocaine-Related Disorders (1)

Interventions

Methylphenidate (1)  ·  Ondansetron (1)

Countries

United States (1)

Top investigators

Ashwin A Patkar, MD (1)  ·  Robert J Noveck, MD,PhD (1)

NIH funding

1RC2DA028905-01 (1)